CASI Pharmaceuticals, Inc. (CASI)
USD 1.95
(-2.01%)
USD 1.95
(-2.01%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 20.05 Million USD | -30.41% |
| 2022 | 27.28 Million USD | 54.9% |
| 2021 | 17.61 Million USD | 212.64% |
| 2020 | 5.63 Million USD | 2773.98% |
| 2019 | 196 Thousand USD | 111.73% |
| 2018 | -1.67 Million USD | -1318.7% |
| 2017 | -117.77 Thousand USD | -77.24% |
| 2016 | -66.45 Thousand USD | -260.36% |
| 2015 | 41.43 Thousand USD | 154.85% |
| 2014 | 16.26 Thousand USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 669.31 Thousand USD | -65.52% |
| 2011 | 1.94 Million USD | -47.45% |
| 2010 | 3.69 Million USD | -30.11% |
| 2009 | 5.28 Million USD | -29.33% |
| 2008 | 7.47 Million USD | 1.1% |
| 2007 | 7.39 Million USD | 7.27% |
| 2006 | 6.89 Million USD | 16.5% |
| 2005 | 5.91 Million USD | 1051.38% |
| 2004 | 513.99 Thousand USD | -67.38% |
| 2003 | 1.57 Million USD | 33.92% |
| 2002 | 1.17 Million USD | -36.81% |
| 2001 | 1.86 Million USD | -60.8% |
| 2000 | 4.74 Million USD | -19.5% |
| 1999 | 5.9 Million USD | 0.0% |
| 1998 | 5.9 Million USD | 15.69% |
| 1997 | 5.1 Million USD | 270.0% |
| 1996 | -3 Million USD | -516.67% |
| 1995 | 720 Thousand USD | 700.0% |
| 1994 | 90 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.8 Million USD | -52.71% |
| 2024 Q2 | 2.06 Million USD | 14.45% |
| 2023 FY | 18.98 Million USD | -30.41% |
| 2023 Q4 | 3.81 Million USD | -26.42% |
| 2023 Q1 | 4.96 Million USD | -54.77% |
| 2023 Q3 | 5.19 Million USD | -11.04% |
| 2023 Q2 | 5.83 Million USD | 17.41% |
| 2022 Q3 | 5.96 Million USD | 18.77% |
| 2022 Q1 | 5.3 Million USD | -1.01% |
| 2022 FY | 27.28 Million USD | 54.9% |
| 2022 Q4 | 10.98 Million USD | 84.16% |
| 2022 Q2 | 5.02 Million USD | -5.3% |
| 2021 Q3 | 4.69 Million USD | 12.32% |
| 2021 Q4 | 5.35 Million USD | 14.12% |
| 2021 FY | 17.61 Million USD | 212.64% |
| 2021 Q1 | 3.37 Million USD | 17.7% |
| 2021 Q2 | 4.18 Million USD | 23.74% |
| 2020 FY | 5.63 Million USD | 2773.98% |
| 2020 Q1 | 195 Thousand USD | 242.11% |
| 2020 Q2 | 154 Thousand USD | -21.03% |
| 2020 Q3 | 2.41 Million USD | 1467.53% |
| 2020 Q4 | 2.87 Million USD | 18.89% |
| 2019 Q3 | 139 Thousand USD | 0.0% |
| 2019 Q4 | 57 Thousand USD | -58.99% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 196 Thousand USD | 111.73% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | -1.67 Million USD | -1318.7% |
| 2018 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | -117.77 Thousand USD | -77.24% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | -66.45 Thousand USD | -260.36% |
| 2016 Q1 | - USD | -100.0% |
| 2015 FY | 41.43 Thousand USD | 154.85% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q2 | 21.26 Thousand USD | 21.82% |
| 2015 Q1 | 17.45 Thousand USD | 7.37% |
| 2015 Q4 | 2711.00 USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | 16.26 Thousand USD | 0.0% |
| 2014 Q4 | 16.26 Thousand USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | -100.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | 669.31 Thousand USD | -65.52% |
| 2012 Q4 | 669.31 Thousand USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q4 | 1.93 Million USD | 0.0% |
| 2011 Q3 | - USD | -100.0% |
| 2011 Q1 | - USD | -100.0% |
| 2011 Q2 | 8852.00 USD | 0.0% |
| 2011 FY | 1.94 Million USD | -47.45% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | 3.69 Million USD | 0.0% |
| 2010 FY | 3.69 Million USD | -30.11% |
| 2010 Q1 | - USD | -100.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | 3.66 Million USD | 0.0% |
| 2009 FY | 5.28 Million USD | -29.33% |
| 2009 Q4 | 1.61 Million USD | -55.95% |
| 2009 Q1 | - USD | -100.0% |
| 2008 FY | 7.47 Million USD | 1.1% |
| 2008 Q1 | - USD | -100.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | 3.5 Million USD | 0.0% |
| 2008 Q4 | 3.97 Million USD | 13.56% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | 7.39 Million USD | 7.27% |
| 2007 Q4 | 3.87 Million USD | 10.09% |
| 2007 Q3 | 3.52 Million USD | 0.0% |
| 2007 Q1 | - USD | -100.0% |
| 2006 FY | 6.89 Million USD | 16.5% |
| 2006 Q3 | 3.02 Million USD | 0.0% |
| 2006 Q4 | 3.87 Million USD | 28.05% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | -100.0% |
| 2005 Q1 | 25.24 Thousand USD | -81.14% |
| 2005 Q4 | 4.06 Million USD | 225.2% |
| 2005 FY | 5.91 Million USD | 1051.38% |
| 2005 Q3 | 1.24 Million USD | 115.65% |
| 2005 Q2 | 579.46 Thousand USD | 2194.99% |
| 2004 Q1 | 97.96 Thousand USD | -81.07% |
| 2004 Q4 | 133.91 Thousand USD | -6.18% |
| 2004 FY | 513.99 Thousand USD | -67.38% |
| 2004 Q3 | 142.73 Thousand USD | 2.41% |
| 2004 Q2 | 139.38 Thousand USD | 42.27% |
| 2003 FY | 1.57 Million USD | 33.92% |
| 2003 Q4 | 517.53 Thousand USD | 100.22% |
| 2003 Q1 | 513.54 Thousand USD | 11.2% |
| 2003 Q3 | 258.47 Thousand USD | -9.62% |
| 2003 Q2 | 285.98 Thousand USD | -44.31% |
| 2002 Q3 | 345.56 Thousand USD | 11.77% |
| 2002 FY | 1.17 Million USD | -36.81% |
| 2002 Q1 | 59.93 Thousand USD | -53.71% |
| 2002 Q2 | 309.17 Thousand USD | 415.89% |
| 2002 Q4 | 461.82 Thousand USD | 33.64% |
| 2001 Q2 | 757.52 Thousand USD | -36.9% |
| 2001 Q4 | 129.47 Thousand USD | 42.3% |
| 2001 FY | 1.86 Million USD | -60.8% |
| 2001 Q1 | 1.2 Million USD | -21.55% |
| 2001 Q3 | 90.98 Thousand USD | -87.99% |
| 2000 Q3 | 1.12 Million USD | 0.72% |
| 2000 FY | 4.74 Million USD | -19.5% |
| 2000 Q1 | 968.98 Thousand USD | 61.5% |
| 2000 Q2 | 1.12 Million USD | 15.7% |
| 2000 Q4 | 1.53 Million USD | 35.52% |
| 1999 Q4 | 600 Thousand USD | -70.0% |
| 1999 FY | 5.9 Million USD | 0.0% |
| 1999 Q3 | 2 Million USD | 33.33% |
| 1999 Q2 | 1.5 Million USD | -11.76% |
| 1999 Q1 | 1.7 Million USD | 6.25% |
| 1998 Q1 | 1.4 Million USD | -6.67% |
| 1998 FY | 5.9 Million USD | 15.69% |
| 1998 Q4 | 1.6 Million USD | 6.67% |
| 1998 Q3 | 1.5 Million USD | 7.14% |
| 1998 Q2 | 1.4 Million USD | 0.0% |
| 1997 Q1 | 1.2 Million USD | 118.46% |
| 1997 Q4 | 1.5 Million USD | 15.38% |
| 1997 FY | 5.1 Million USD | 270.0% |
| 1997 Q3 | 1.3 Million USD | 18.18% |
| 1997 Q2 | 1.1 Million USD | -8.33% |
| 1996 Q2 | 1.2 Million USD | 9.09% |
| 1996 Q3 | 1.2 Million USD | 0.0% |
| 1996 Q4 | -6.5 Million USD | -641.67% |
| 1996 FY | -3 Million USD | -516.67% |
| 1996 Q1 | 1.1 Million USD | 89.66% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | 720 Thousand USD | 700.0% |
| 1995 Q2 | 90 Thousand USD | 0.0% |
| 1995 Q3 | 50 Thousand USD | -44.44% |
| 1995 Q4 | 580 Thousand USD | 1060.0% |
| 1994 FY | 90 Thousand USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | 147.915% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 78.831% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 98.679% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 39619.117% |
| Apollomics, Inc. | 127 Thousand USD | -15688.976% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 19075.16% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 87282.609% |
| Bicycle Therapeutics plc | -129.52 Million USD | 115.482% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -2400.249% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -16610.0% |
| Chimerix, Inc. | 324 Thousand USD | -6088.889% |
| CRISPR Therapeutics AG | 240.95 Million USD | 91.678% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 59.739% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 51.549% |
| Fortress Biotech, Inc. | 57.85 Million USD | 65.34% |
| Fortress Biotech, Inc. | 57.85 Million USD | 65.34% |
| Gritstone bio, Inc. | -6.26 Million USD | 420.319% |
| Allakos Inc. | -6.14 Million USD | 426.527% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 2195.298% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -35.541% |
| Cytokinetics, Incorporated | -322.59 Million USD | 106.216% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 11558.286% |
| Innoviva, Inc. | 261.06 Million USD | 92.319% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 175871.388% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 664.686% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 199602.537% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 2376.05% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 5125.564% |
| ImmuCell Corporation | 4.39 Million USD | -356.112% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 118.895% |
| Incyte Corporation | 3.44 Billion USD | 99.417% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 850.582% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -10198.498% |
| Mustang Bio, Inc. | -2.22 Million USD | 1001.213% |
| MiMedx Group, Inc. | 266.84 Million USD | 92.485% |
| MEI Pharma, Inc. | 49.32 Million USD | 59.349% |
| MacroGenics, Inc. | 50.52 Million USD | 60.314% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | -170.024% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 382.198% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 30.986% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 85.698% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 64821.451% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 20772.165% |
| NextCure, Inc. | -3.68 Million USD | 644.3% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -679.021% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -5.299% |
| Onconetix, Inc. | -1.12 Million USD | 1878.976% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 169.221% |
| Opthea Limited | 21.72 Thousand USD | -92220.442% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 1764.232% |
| Psyence Biomedical Ltd. | -240.00 USD | 8355100.0% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 35078.893% |
| Precigen, Inc. | 106 Thousand USD | -18816.981% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -1887.314% |
| Prime Medicine, Inc. | -147.9 Million USD | 113.557% |
| PureTech Health plc | -1.6 Million USD | 1350.905% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 382.502% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.823% |
| Replimune Group, Inc. | -2.65 Million USD | 855.254% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 80151.1% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 81.733% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 3980.436% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 105.017% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 49.87% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 144.24% |
| Solid Biosciences Inc. | -76.56 Million USD | 126.19% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 167200.0% |
| SciSparc Ltd. | 2.19 Million USD | -813.115% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 175.118% |
| TG Therapeutics, Inc. | 219.1 Million USD | 90.848% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -562.438% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 1259.746% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 85.012% |
| UroGen Pharma Ltd. | 73.35 Million USD | 72.663% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -358.017% |
| XOMA Corporation | 3.86 Million USD | -419.347% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 1543.629% |
| AbCellera Biologics Inc. | 38.02 Million USD | 47.266% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 401140.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | 122.424% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 164.336% |
| Precision BioSciences, Inc. | 40.47 Million USD | 50.455% |
| Dyadic International, Inc. | 922.95 Thousand USD | -2072.582% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 13740.816% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 4.791% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -4629.245% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 330.828% |
| IGM Biosciences, Inc. | -211.66 Million USD | 109.474% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 1104.609% |
| Acelyrin, Inc. | -115 Thousand USD | 17536.522% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -723.491% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 83.256% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 250.114% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 87.046% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 120.416% |
| Senti Biosciences, Inc. | -2.68 Million USD | 847.372% |
| Mesoblast Limited | -9.81 Million USD | 304.3% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 118.148% |
| ChromaDex Corporation | 50.78 Million USD | 60.512% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 83.356% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -185.356% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 85.176% |
| Novavax, Inc. | 639.93 Million USD | 96.867% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 120.427% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 146.136% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -15324.615% |
| Celcuity Inc. | -142.77 Thousand USD | 14144.771% |
| ContextLogic Inc. | 59 Million USD | 66.014% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -3793.592% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -20.963% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 99.41% |
| Amarin Corporation plc | 165.54 Million USD | 87.887% |
| AnaptysBio, Inc. | 14.78 Million USD | -35.661% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 3636.508% |
| Aptorum Group Limited | -1.11 Million USD | 1898.889% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 17.991% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 91.671% |
| Ardelyx, Inc. | 106.66 Million USD | 81.2% |
| Celularity Inc. | 6.75 Million USD | -196.847% |
| Omeros Corporation | -69.77 Million USD | 128.736% |
| Humacyte, Inc. | -76.55 Million USD | 126.195% |
| Immunocore Holdings plc | 248.39 Million USD | 91.927% |
| IO Biotech, Inc. | -756 Thousand USD | 2752.381% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 1506.171% |
| Summit Therapeutics Inc. | -2.05 Million USD | 1078.146% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 517.924% |
| Pulmatrix, Inc. | -8.22 Million USD | 343.942% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 105.028% |
| Evogene Ltd. | 1.39 Million USD | -1333.31% |
| CorMedix Inc. | -205.56 Thousand USD | 9854.721% |
| BioLineRx Ltd. | 1.1 Million USD | -1709.747% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -3942.742% |
| Sagimet Biosciences Inc. | 2 Million USD | -902.6% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 97.701% |
| scPharmaceuticals Inc. | 9.78 Million USD | -104.989% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 129.063% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 95.786% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 175871.388% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 69244.828% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 10709.524% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -394.989% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 3919.429% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 45478.836% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 291.978% |
| Daré Bioscience, Inc. | 2.76 Million USD | -624.024% |
| bluebird bio, Inc. | -4.03 Million USD | 597.568% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 98.947% |
| DBV Technologies S.A. | 15.72 Million USD | -27.492% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 111.054% |
| Galecto, Inc. | -830 Thousand USD | 2515.904% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 3611.734% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 150.967% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -3192.611% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 14092.924% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 63.288% |
| ADMA Biologics, Inc. | 88.21 Million USD | 77.27% |
| Clene Inc. | 533 Thousand USD | -3662.101% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -908.652% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 4325.521% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 192907.692% |
| Soligenix, Inc. | 97.31 Thousand USD | -20506.098% |
| Century Therapeutics, Inc. | -10.8 Million USD | 285.512% |
| Kura Oncology, Inc. | -849 Thousand USD | 2461.837% |
| Surrozen, Inc. | -27.23 Million USD | 173.639% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 129.882% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 79.753% |
| Autolus Therapeutics plc | -4.86 Million USD | 511.999% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 12035.714% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 125.841% |
| GRI Bio, Inc. | 10.84 Million USD | -84.964% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -689.453% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 142.81% |
| INmune Bio, Inc. | 155 Thousand USD | -12836.774% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 67.626% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 1431.217% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 3192.278% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 264987.715% |
| Jaguar Health, Inc. | 7.72 Million USD | -159.606% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 68597.643% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -4888.06% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -154.758% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 6506.39% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 78.772% |
| Verastem, Inc. | -62 Thousand USD | 32441.935% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 7782.759% |
| Histogen Inc. | 3.76 Million USD | -432.024% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -3380.168% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 97.054% |
| Surrozen, Inc. | -27.23 Million USD | 173.639% |
| Organovo Holdings, Inc. | -5.38 Million USD | 472.091% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 1012827.273% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -230.541% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 29969.956% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -13653.086% |
| Kronos Bio, Inc. | 1.37 Million USD | -1361.516% |
| Turnstone Biologics Corp. | 16.5 Million USD | -21.483% |
| Synaptogenix, Inc. | -6347.00 USD | 316028.785% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 39417.647% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 31.161% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 87.574% |
| Exelixis, Inc. | 1.75 Billion USD | 98.859% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 117.878% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 94.069% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 1909.747% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 17022.804% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -174.009% |
| Insmed Incorporated | 239.63 Million USD | 91.632% |
| MediWound Ltd. | 3.57 Million USD | -460.425% |
| OmniAb, Inc. | 14.66 Million USD | -36.715% |
| Alector, Inc. | -95.05 Million USD | 121.096% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 84.038% |
| Zai Lab Limited | 170.9 Million USD | 88.267% |
| AlloVir, Inc. | -398 Thousand USD | 5138.191% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 75.51% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 2043.023% |
| Aura Biosciences, Inc. | -1.29 Million USD | 1648.417% |
| Immunic, Inc. | -111 Thousand USD | 18164.865% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -26.479% |
| Veracyte, Inc. | 248.14 Million USD | 91.919% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.287% |
| FibroGen, Inc. | 128.9 Million USD | 84.444% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 93.607% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 3555419.149% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 271.871% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -5054.756% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 94.357% |
| Fortrea Holdings Inc. | 424 Million USD | 95.271% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 123.271% |
| XBiotech Inc. | -1.74 Million USD | 1249.771% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 1909.747% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 3119.88% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 143.149% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 126.547% |
| Agenus Inc. | 139.61 Million USD | 85.638% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 72.682% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -19.336% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 94.846% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 140.389% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 93.863% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 277.078% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 120.683% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -371233.333% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 30105.836% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 11568.575% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 5461.497% |
| Ainos, Inc. | -253.73 Thousand USD | 8002.795% |
| Pluri Inc. | 322 Thousand USD | -6127.329% |
| Prothena Corporation plc | -129.2 Million USD | 115.52% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 60.233% |
| Rallybio Corporation | -150 Thousand USD | 13468.0% |
| Kodiak Sciences Inc. | -25.94 Million USD | 177.281% |
| Cue Biopharma, Inc. | -32.6 Million USD | 161.496% |
| MeiraGTx Holdings plc | 287 Thousand USD | -6886.76% |
| Annexon, Inc. | -3.26 Million USD | 713.774% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 148.044% |
| Moderna, Inc. | 2.15 Billion USD | 99.07% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 232.191% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 67.856% |
| Blueprint Medicines Corporation | 236.58 Million USD | 91.524% |
| Immix Biopharma, Inc. | -5468.00 USD | 366815.435% |
| CalciMedica, Inc. | -58 Thousand USD | 34672.414% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 422.276% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 805.063% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 80.738% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 164.967% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 1813.846% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -622.442% |
| Nutriband Inc. | 862.1 Thousand USD | -2225.935% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 5980.352% |
| Vor Biopharma Inc. | -3.49 Million USD | 674.227% |
| Roivant Sciences Ltd. | 109.23 Million USD | 81.643% |
| Alkermes plc | 1.37 Billion USD | 98.541% |
| ProKidney Corp. | -3.16 Million USD | 732.755% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 145.664% |
| Arcellx, Inc. | 108.27 Million USD | 81.481% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -192.431% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 125.488% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 60863.636% |
| Atai Life Sciences N.V. | -5000.00 USD | 401140.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 16555.083% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 20987.5% |
| MediciNova, Inc. | 979.7 Thousand USD | -1946.739% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 123.781% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 21306.705% |
| GeoVax Labs, Inc. | -20.72 Million USD | 196.772% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 91.8% |
| Biomea Fusion, Inc. | -4.2 Million USD | 577.315% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 6568.387% |
| Geron Corporation | -123.5 Million USD | 116.236% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 401140.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 126.255% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 914.791% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 90.618% |
| Royalty Pharma plc | 1.79 Billion USD | 98.882% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 2230.925% |
| Imunon, Inc. | -720 Thousand USD | 2884.981% |
| BioAtla, Inc. | -103.73 Million USD | 119.331% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 108.258% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 6547.588% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 117.998% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 2212.574% |
| 89bio, Inc. | -273 Thousand USD | 7445.055% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 128.611% |
| aTyr Pharma, Inc. | -2.38 Million USD | 939.698% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -60.931% |
| Viridian Therapeutics, Inc. | -1 Million USD | 2089.286% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -154246053.846% |
| Akari Therapeutics, Plc | -4000.00 USD | 501400.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 96.852% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -1691.957% |
| Liquidia Corporation | 14.6 Million USD | -37.342% |
| Entera Bio Ltd. | -56 Thousand USD | 35907.143% |
| GH Research PLC | -315 Thousand USD | 6465.714% |
| Vericel Corporation | 135.57 Million USD | 85.21% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 136.091% |
| Xencor, Inc. | -85.26 Million USD | 123.519% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 9174.248% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 3192.278% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 2102.725% |
| Vaxcyte, Inc. | -75 Million USD | 126.736% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 111.97% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 88.725% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -10198.498% |
| Portage Biotech Inc. | -54 Thousand USD | 37233.333% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 21306.705% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 5418.833% |
| OncoCyte Corporation | 413 Thousand USD | -4755.206% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 446195.662% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 9032532.432% |
| Purple Biotech Ltd. | -196 Thousand USD | 10330.612% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 5362.992% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 191.199% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 70.566% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -123.595% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 15888.976% |
| United Therapeutics Corporation | 2.07 Billion USD | 99.031% |
| HilleVax, Inc. | -2.15 Million USD | 1030.056% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -30160.775% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 608.67% |
| Pharming Group N.V. | 220.1 Million USD | 90.89% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 133744.362% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 3101.796% |
| Pyxis Oncology, Inc. | -2 Million USD | 1102.6% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 267240.589% |
| Savara Inc. | -44.26 Million USD | 145.303% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 24553.659% |
| Curis, Inc. | 9.81 Million USD | -104.383% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 16168.853% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 8894.737% |
| BeiGene, Ltd. | 2.07 Billion USD | 99.035% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 64.627% |
| Erasca, Inc. | -3.73 Million USD | 637.299% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 71161.025% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 71161.025% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 2291.475% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -150.462% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 3841.045% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 118.044% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 658.863% |
| Adicet Bio, Inc. | -6.09 Million USD | 428.829% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 94.461% |
| Aditxt, Inc. | -111.66 Thousand USD | 18058.087% |
| Adagene Inc. | 18.11 Million USD | -10.714% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -4009.016% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 87.296% |
| Compugen Ltd. | 31.45 Million USD | 36.252% |
| Generation Bio Co. | -73.91 Million USD | 127.13% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 4688.558% |
| Invivyd, Inc. | -2.02 Million USD | 1088.757% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 106.665% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 19485.526% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 79.192% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 79.599% |
| Instil Bio, Inc. | -4.75 Million USD | 521.615% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 16.828% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -1667.35% |
| GeoVax Labs, Inc. | -20.72 Million USD | 196.772% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 10419.274% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 2498.565% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 75.961% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -27326.414% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 62.281% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 111.578% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 5780.453% |
| Cingulate Inc. | -582.91 Thousand USD | 3539.935% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 64783.871% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 201.792% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 2129.555% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 35689.791% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 137.364% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 6967.123% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 3904.934% |
| ImmunityBio, Inc. | -17.89 Million USD | 212.085% |
| Korro Bio, Inc. | -3.63 Million USD | 652.397% |
| Kineta, Inc. | 5.43 Million USD | -269.078% |
| BioVie Inc. | -229.37 Thousand USD | 8841.94% |
| Codexis, Inc. | 57.33 Million USD | 65.026% |
| Celularity Inc. | 6.75 Million USD | -196.847% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 16950.42% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -399.676% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -39536.292% |
| Cibus, Inc. | 1.42 Million USD | -1310.127% |
| IN8bio, Inc. | -2.5 Million USD | 901.759% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 1081.018% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -3033.125% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 97.424% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 88.406% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | 51515.385% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 1155.368% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 161.948% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 74.683% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 194.8% |
| Moolec Science SA | -143.3 Thousand USD | 14092.533% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 147.384% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -510.04% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 128.609% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 1160.952% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 555249.502% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -8565.851% |
| Humacyte, Inc. | -76.55 Million USD | 126.195% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 1695.227% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 2464.623% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 16402.439% |
| Notable Labs, Ltd. | 113 Thousand USD | -17645.133% |
| Immunovant, Inc. | -231 Thousand USD | 8780.519% |
| Quantum-Si incorporated | 488 Thousand USD | -4009.016% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 66940.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -976.907% |
| Acasti Pharma Inc. | -11 Thousand USD | 182390.909% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 9899.772% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 1124.106% |
| PepGen Inc. | -1.18 Million USD | 1793.581% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 187.575% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 24381.026% |
| Immuneering Corporation | -764.13 Thousand USD | 2724.133% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | -399 Thousand USD | 5125.564% |
| XOMA Corporation | 3.86 Million USD | -419.347% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 200.08% |
| Bionomics Limited | -434.44 Thousand USD | 4715.501% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 1967.039% |
| uniQure N.V. | 2.21 Million USD | -805.282% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 121.779% |
| Forte Biosciences, Inc. | -9000.00 USD | 222900.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 2501.437% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 4688.558% |
| Altimmune, Inc. | -65.37 Million USD | 130.673% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 933.07% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 1967.039% |
| Peak Bio, Inc. | 367.76 Thousand USD | -5352.336% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 18.209% |
| Benitec Biopharma Inc. | 108 Thousand USD | -18466.667% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 25807.692% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 1766.833% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 1200.549% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 1766.833% |
| argenx SE | 1.1 Billion USD | 98.191% |
| Immunome, Inc. | -8.9 Million USD | 325.126% |
| Verona Pharma plc | -679.62 Thousand USD | 3050.455% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 11558.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | 940.755% |
| CervoMed Inc. | -1.29 Million USD | 1650.06% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 519.761% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -711.493% |
| Moolec Science SA | -143.3 Thousand USD | 14092.533% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 5014.345% |
| Design Therapeutics, Inc. | -537 Thousand USD | 3834.078% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 4796.019% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -834.39% |
| Achilles Therapeutics plc | -4.73 Million USD | 523.819% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 144.024% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -46532.558% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 2539.416% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 152493.981% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 60863.636% |
| Beam Therapeutics Inc. | -59.67 Million USD | 133.604% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 85.609% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 6.93% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 6851.515% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 597.934% |
| NeurAxis, Inc. | 2.15 Million USD | -829.752% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 309.617% |
| Lumos Pharma, Inc. | 2 Million USD | -899.103% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 36.662% |
| Palisade Bio, Inc. | 246 Thousand USD | -8051.22% |
| Nutriband Inc. | 862.1 Thousand USD | -2225.935% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -42.415% |
| Neurogene Inc. | -3.26 Million USD | 714.715% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 36558.182% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 643.12% |
| Athira Pharma, Inc. | -969 Thousand USD | 2169.35% |
| HCW Biologics Inc. | -574.82 Thousand USD | 3588.372% |
| XOMA Corporation | 3.86 Million USD | -419.347% |
| Nektar Therapeutics | 53.47 Million USD | 62.504% |
| Arvinas, Inc. | 71.8 Million USD | 72.072% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 124.026% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 131.943% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 6327.329% |
| Rezolute, Inc. | -36 Thousand USD | 55800.0% |
| Clene Inc. | 533 Thousand USD | -3662.101% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 1561782.243% |
| BeyondSpring Inc. | 1.75 Million USD | -1045.174% |
| Synlogic, Inc. | -1.92 Million USD | 1142.204% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 54294.595% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 416.677% |
| Peak Bio, Inc. | 367.76 Thousand USD | -5352.336% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 205.743% |
| Krystal Biotech, Inc. | 47.6 Million USD | 57.878% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 85.788% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -299.045% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 874.442% |
| MannKind Corporation | 136.19 Million USD | 85.277% |
| Ikena Oncology, Inc. | -50.49 Million USD | 139.713% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 81.572% |
| Gossamer Bio, Inc. | -4.38 Million USD | 557.286% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 8057.143% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 401140.0% |
| Legend Biotech Corporation | 140.92 Million USD | 85.772% |
| Mural Oncology plc | -2.56 Million USD | 881.145% |
| Disc Medicine, Inc. | -100 Thousand USD | 20152.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 3.382% |
| REGENXBIO Inc. | 53.02 Million USD | 62.187% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 474.317% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 10523.392% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 1257.737% |
| Vaxart, Inc. | -60.76 Million USD | 133.0% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 7730.718% |
| Cellectis S.A. | 18 Thousand USD | -111300.0% |
| Longeveron Inc. | 221 Thousand USD | -8973.303% |
| Repare Therapeutics Inc. | -80.07 Million USD | 125.043% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 98.165% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 1649.614% |
| Revolution Medicines, Inc. | -399.66 Million USD | 105.017% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 57391.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -40822.449% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.767% |
| Denali Therapeutics Inc. | -93.34 Million USD | 121.482% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 80151.1% |
| Veru Inc. | 7.56 Million USD | -165.03% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 13379.47% |
| Cingulate Inc. | -582.91 Thousand USD | 3539.935% |
| Passage Bio, Inc. | -3.72 Million USD | 638.887% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 166589.538% |
| Exicure, Inc. | -1.42 Million USD | 1509.136% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 5335.509% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -641.842% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 4011.25% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 13503.116% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 133.868% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -5028.389% |
| OmniAb, Inc. | 14.66 Million USD | -36.715% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -0.295% |
| Lipocine Inc. | -2.85 Million USD | 803.377% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 1188.009% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 451.481% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 1431.217% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 73.376% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 30949.231% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 76.212% |
| Ocugen, Inc. | -33.53 Million USD | 159.791% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 734.156% |
| Q32 Bio Inc. | 578 Thousand USD | -3369.204% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 7666.792% |
| Alumis Inc. Common Stock | -1.28 Million USD | 1661.682% |
| Equillium, Inc. | 35.95 Million USD | 44.235% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 1274.692% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -3904.961% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 485150.798% |
| Dominari Holdings Inc. | 2.03 Million USD | -883.423% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 11029.248% |
| vTv Therapeutics Inc. | -13.59 Million USD | 247.495% |
| Bio-Techne Corporation | 773.07 Million USD | 97.406% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -15.78% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 95.648% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 1815.312% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 183.62% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -71.429% |
| Nkarta, Inc. | -5.86 Million USD | 441.66% |
| BioCardia, Inc. | -7.24 Million USD | 376.617% |
| Iterum Therapeutics plc | -1.75 Million USD | 1245.829% |